genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Lymphoma
Jakafi Success Helps Incyte Land Blockbuster MorphoSys Partnership
GEN Edge
Illumina, Roche Launch NGS-Based Cancer Diagnostics Partnership
GEN Edge
From J.P. Morgan: Cell, Gene Therapy to Drive Biopharma M&A in…
GEN Edge
AGTC Plans Pivotal Trial for XLRP Gene Therapy
GEN Edge
TwinStrand’s Duplex Sequencing Goes Deep
News
Bioprocessing
3i Establishes a Single-Use Bioprocessing Platform
Nutrition
Walnuts Promote Heart Healthy Microbiome
News
Real Risks Shown with Cannabis Exposure During Pregnancy
News
Tuberculosis Onset Predicted by Gene Expression Blood Test
News
Cells Huddle to Cope with Stress, Defy Cancer Meds
Insights
All
Trends for 2020
Bioprocessing
Applying the Bioprocessing 4.0 Paradigm to Antibody Glycosylation
Bioprocessing
Working in Biopharma Globally
ALS
Neurodegenerative Treatments Build to a Tipping Point
Insights
Silencing Breast Cancer Genes Using Morpholino Embedded DNA-Tile-AuNPs Nanostructures
A-Lists
Insights
Top 10 Young Companies in the Money, 2019
January 2020 Vol. 40 No. 1
8 Biopharma Trends to Watch in 2020
Cancer
Top 10 Immuno-Oncology Startups of 2019
Drug Discovery
Top 10 Pharma Companies of 2019
December 2019 Vol. 39 No. 12
Top 25 Biotech Companies of 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Bioprocessing
FDA Backing and Efficiency Drive Bioprocess Innovation
Bioprocessing
3i Establishes a Single-Use Bioprocessing Platform
Bioprocessing
Applying the Bioprocessing 4.0 Paradigm to Antibody Glycosylation
Bioprocessing
Working in Biopharma Globally
Magazine
Artificial Intelligence
The Outlook for 2020 and Beyond
January 2020 Vol. 40 No. 1
Super-Resolution Microscopy Comes into Focus
January 2020 Vol. 40 No. 1
Biopharma’s Lab of the Future Can’t Wait
January 2020 Vol. 40 No. 1
Convergence Fends Off Malthus
January 2020 Vol. 40 No. 1
From CRISPR Multiplexing to Pleistocene Park
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
GENcast
Find the Right Fit when Tackling Late Stage Bioprocessing Challenges
Upcoming Webinars
Get Fired Up about Multiplexed Biomarker Profiling
Upcoming Webinars
Designing Next-Generation Regulatory T Cell Therapies with Single-Cell Proteomics
January 2020 Vol. 40 No. 1
Experimental Program Design Considerations for Optimized Use of Preclinical Models in…
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Cancer
Lymphoma
Lymphoma
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Lymphoma
Jakafi Success Helps Incyte Land Blockbuster MorphoSys Partnership
Lymphoma
Catalent Agrees to Manufacture BeiGene’s Tyrosine Kinase Inhibitor for Lymphoma Therapy
Lymphoma
Allogene, Notch Partner to Develop iPSC-Derived Blood Cancer Therapies
Lymphoma
Janssen, Genmab Partner on Follow-On to Darzalex for Multiple Myeloma, Diffuse Large B-Cell Lymphoma
Lymphoma
Lymphoma Resistance Mechanism to Chemo Drug Identified
Lymphoma
Cancer Drug Developers GTx, Oncternal Plan Reverse Merger
Lymphoma
FDA Approves First Non-Chemo Combination Therapy for a Form of Leukemia
Lymphoma
Harbour BioMed to Develop Kelun-Biotech’s Cancer Immunotherapy Candidate A167
Lymphoma
Epizyme Halts Phase II Trial of Tazemetostat in DLBCL Cohorts, Continues...
Lymphoma
Aggressive Lymphoma Linked with JAK Inhibitor Use
Lymphoma
FDA Imposes Partial Clinical Hold on Epizyme Lead Candidate after Patient...
Lymphoma
MorphoSys to Advance Pipeline, Platform Through Up-to-$150M U.S. IPO
Lymphoma
Kite, Pfizer to Assess Yescarta-Utomilumab Combination in Lymphoma
Lymphoma
Chimera Virus Constructed for Potential New Lymphoma Therapy
Lymphoma
Cancer Cell Therapy Developer Kite Pharma Finds $11.9B Buyer in Gilead
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; }
